Q2 2023 Coloplast A/S Earnings Call Transcript
Ladies and gentlemen, thank you for standing by. Welcome, and thank you for joining the Coloplast First Half 2022/2023 Earnings Release Conference Call. (Operator Instructions) I would now like to turn the conference over to Kristian Villumsen, President and CEO. Please go ahead.
/-&
Thank you very much, operator. Good morning, and welcome to our first half '22-'23 conference call. My name is Kristian Villumsen. I'm the CEO of Coloplast, and I'm joined by our CFO, Anders Skovgaard and our Investor Relations team. We'll start with a short presentation by Anders and myself and then open up for questions like we usually do.
Could I ask you all to turn to Slide #3. We delivered 8% organic growth and reported EBIT margin before special items of 28% in the second quarter. Return on invested capital after tax and before special items was 19%, which reflects the impact from the Atos Medical acquisition. I'm satisfied with our performance. We continue to broadly
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
